(16 Jun 2020) A British trial organised at Oxford University has discovered a drug called Dexamethasone reduces fatalities among severely ill coronavirus patients.
Peter Horby, the co-chief investigator of the Recovery Trial - Randomised Evaluation of COVID-19 Therapy - said about 75% of patients in hospital will receive a mortality benefit from using the drug.
Over three months, the university enrolled over 11,000 patients, Horby says making it "by far the biggest clinical trial in the world".
Trialing 6 different types of drugs, in the last week it was discovered steroid drug Dexamethasone had a "significant effect" on patients with breathing difficulties.
In ventilated patients with COVID-19, the drug reduced risk of death by about 35%.
In patients needing oxygen treatment, it reduced risk of death by about 20%.
Horby said the drug itself is stocked in "every pharmacy", it is available throughout the world and is "extremely cheap".
Find out more about AP Archive: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
